Search alternatives:
"pharmaceutical company" » "pharmaceutical companies"

301
Published 2017
Humana
... for improved clinical management and to support the development of new drugs by pharmaceutical companies, due...

302
by Gieschke, Ronald, Serafin, Daniel
Published 2014
Springer Berlin Heidelberg
... approaches. This inspired all major pharmaceutical companies to pursue alternative model-based paradigms...

303
Published 1997
Springer Netherlands
... and pharmaceutical companies are endeavouring to expedite the drug development process, Regulatory Authorities...

304
Published 1992
Springer US
... and drug-discovery investigators in pharmaceutical companies, also extend these theoretical concerns...

305
Published 1997
Humana
...Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia...

306
Published 2004
Humana
... pharmaceutical companies from all over the world provide proven solutions to this expensive problem with a...

307
Published 2004
Humana Press
... pharmaceutical companies from all over the world provide proven solutions to this expensive problem with a...

308
Published 2003
Birkhäuser
... as used by pharmaceutical companies and research institutes. It comprehensively covers proteomics...

309
Published 1987
Springer Netherlands
...­ thusiastically by people and financial assistance given most generously by those pharmaceutical companies listed...

310
Published 2019
Springer Nature Singapore
...’ profitable lifecycle, giving pharmaceutical companies competitive and financial advantages, and providing...

311
Published 1984
Springer Berlin Heidelberg
... by national health agencies and by multinational pharmaceutical companies, contributed to an upsweep in public...

312
by Kwon, Younggil
Published 2002
Springer US
... metabolism departments, but also for other discovery and development groups in pharmaceutical companies...

313
by Dominique Massotte
Published 2015
Frontiers Media SA
... for drug design in pharmaceutical companies since they constitute the target of about one third...